Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
DATE PUBLISHED: 2019 Sep
JOURNAL:Int Immunopharmacol
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/31252248?dopt=Abstract
Volume:74
A meta-analysis was performed to assess the risk of common adverse events in melanoma patients treated with checkpoint inhibitors.
